Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/1b First-in-human Study of BMS-986463 in Advanced Malignant Tumors

NCT06476808 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT06476808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06476808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/1b First-in-human Study of BMS-986463 in Advanced Malignant Tumors
Lead sponsor
Bristol-Myers Squibb
Phase
Phase 1
Overall status
Recruiting
Start date
September 6, 2024
Completion date
December 19, 2028
Enrollment
240 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

high-grade serous ovarian carcinoma (hgsoc), non-small cell lung cancer (nsclc), uterine serous carcinoma (usc)